Scholarly record
CURRENT ASPECTS CONCERNING QUANTIFICATION OF PHARMACEUTICAL WASTE FROM WATER SOURCES
Abstract
As a result of increasing water consumption by pharmaceutical industries, hospitals, and the population, large volumes of liquids discharges containing pharmaceutical compounds have been generated worldwide. Even though there is a consistent contribution on the sustainable management of these contaminants, the efforts to reduce this pollution are progressing on a rather small scale. Such pollutants can be introduced into water-receiving bodies either directly, through animal and human excretions, or through unregulated disposal and anthropogenic activities, resulting in their presence in small amounts in aqueous systems. Even if they are in small amounts these classes of contaminants are persistent or partially degraded during treatment processes and thus may cause adverse effects on human and animal health as a result of bioaccumulation. This paper summarizes the main aspects referring to quantification of pharmaceutical waste from both drinkable and industrial waters in order to provide efficient solutions to counteract their negative impact on environment and human health.
Publication Impact Profile
- Captures
- Mendeley - Readers: 2
Publication details
References14
WHO, Pharmaceuticals in Drinking Water, WHO Library Cataloguing-in-Publication Data. ISBN: 978 924 150 2085, France 2012.
Patel, M., Kumar, R., Kishor, K., Mlsna, T., Pittman, C.U., Jr., Mohan, D., Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods, Chemical Review, American Chemical Society, 2019. DOI: 10.1021/acs.chemrev.8b00299
Taylor, D., Senac, T., Human Pharmaceutical Products in the Environment � the �Problem� in Perspective, Chemosphere, 115:95-9, 2014. DOI: 10.1016/j.chemosphere.2014.01.011
Daughton, C.G., Non-Regulated Water Contaminants: Emerging Research, Env. Impact Assess. Rev., 24(7-8), pp 711-732, 2004. DOI: 10.1016/j.eiar.2004.06.003
Fatta-Kassinos, D., Meric, S., Nikolaou, A., Pharmaceutical Residues in Environmental Waters and Wastewater: Current State of Knowledge and Future Research, Anal. Bioanal. Chem., 399(1):251-75, 2011. DOI: 10.1007/s00216-010-4300-9
Baird R., Bridgewater I., American Public Health Association, American Water Works Association, Water Environment Federation, 2017, Standard Methods for the Examination of Water and Wastewater, 23rd Ed. American Public Health Association (APHA), Washington, D.C.
Cai, M.Q., Wang, R., Feng, L., Zhang, L.Q., Determination of Selected Pharmaceuticals in Tap Water and Drinking Water Treatment Plant by High-Performance Liquid Chromatography-Triple Quadrupole Mass Spectrometer in Beijing, China, Environ. Sci. Pollut. Res. Int., 2015, 22(3):1854-67. DOI: 10.1007/s11356-014-3473-8
Lin, Y.C., Lai, W.W.-P., Tung, H.-h., Lin, A.Y.-C., Occurrence of Pharmaceuticals, Hormones and Perfluorinated Compounds in Groundwater in Taiwan, Environ. Monit. Assess. 2015, 187(5):256. DOI: 10.1007/s10661-015-4497-3
Petrovic, M., Skrbic, B., Zimoncev, J., Ferrando-Climent, L., Barcelo, D., Determi-nation of 81 Pharmaceutical Drugs by High Performance of Liquid Chromatography Coupled to Mass Spectrometry with Hybrid Triple Quadrupole � Linear Ion Trap in Different Types of Water in Serbia, Sci. Total Environ., 2014, 15:468-469:415-28. DOI: 10.1016/j.scitotenv.2013.08.079
Riva, F., Castiglioni, S., Fattore, E., Manenti, A., Davoli, E., Zuccato, E., Monitoring Emerging Contaminants in the Drinking Water of Milan and Assessment of the Human Risk, Int. J. Hyg. Environ. Health., 2018, 221(3), pp 451-457. DOI: 10.1016/j.ijheh.2018.01.008
Subedi, B., Codru, M., Dziewulski, D.M., Wilson, L.R., Xue, J., Yun, S., Braun- Howland, E., Minihane, C., Kannan, K., A Pilot Study on the Assessment of Trace Organic Contaminants Including Pharmaceuticals and Personal Care Products from on-Site Wastewater Treatment Systems Along Skaneateles Lakes in New York State, USA, Water Res., 2015, 1:72, pp 28-39. DOI: 10.1016/j.watres.2014.10.049
Kimwian, K., Toshima, S., Amy, G., Werternabe, Y., Rejection of Neutral Endocrine Disrupting Compounds (EDCs) and Pharmaceutical Active Compounds (PhACs) by RO Membranes, J Membrane Sci, 2004, 245(1-2), pp 71-78. DOI: 10.1016/j.memsci.2004.07.018
Ternes, T.A., Joss, A., Siegrist, H., Peer reviewed: scrutinizing pharmaceuticals and personal care products in wastewater treatment, Environ. Sci. Technol., 2004, 38, 20, pp 392A�399A. DOI: 10.1021/es040639t
Schwab, B.W., Hayes, E.P., Fiori, J.M., Mastrocco, F.J., Roden, N.M., Cragin, D., Meyerhoff, R.D., Vincent, J., D�Aco, V.J., Anderson, P.D., Human pharmaceuticals in U.S. surface waters: a human health risk assessment, Regul. Toxicol. Pharmaceutical., 2005, 42(3), pp 296-312. DOI: 10.1016/j.yrtph.2005.05.005
View or Download full articleAccess options
SWS access login
Login as SWS Scientific CommitteeLogin as SWS Scientific PartnerLogin as SWS AuthorAuthors and approved SWS contributors will read and export their own linked papers after identity matching by SWS profile, email and SGEM GlobalID.
For librarian assistance: [email protected]
Purchase Instant Access
- Article can be downloaded after successful payment.
- Article may be used according to SWS library access terms.
- Article cannot be redistributed.